AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 126 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $459,000 | +1175.0% | 638,600 | +3935.9% | 0.01% | +1000.0% |
| Q4 2021 | $36,000 | -83.4% | 15,823 | -79.0% | 0.00% | -83.3% |
| Q3 2021 | $217,000 | +13.0% | 75,240 | +48.2% | 0.01% | 0.0% |
| Q2 2021 | $192,000 | +65.5% | 50,772 | +48.0% | 0.01% | +50.0% |
| Q1 2021 | $116,000 | +114.8% | 34,302 | +77.4% | 0.00% | +100.0% |
| Q4 2020 | $54,000 | +3.8% | 19,332 | -6.2% | 0.00% | -33.3% |
| Q3 2020 | $52,000 | -81.3% | 20,620 | -71.0% | 0.00% | -88.0% |
| Q3 2019 | $278,000 | -67.4% | 71,000 | -31.7% | 0.02% | -69.9% |
| Q1 2019 | $852,000 | +134.1% | 104,000 | +57.9% | 0.08% | +56.6% |
| Q4 2018 | $364,000 | – | 65,852 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |